Sirona Medical Technologies, Inc.
Windsor, CT
- UEI
- UZJPSMDMA814
- CAGE
- 19YF1
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 360 Bloomfield Ave #301, Windsor, CT 06095, USA
- Website
- sironamed.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Sirona Medical Technologies, Inc. develops and commercializes proprietary cardiac ablation catheters and energy-delivery equipment as a prime recipient of federal research and development grants from the National Institutes of Health and the Defense Health Agency. The company is a for-profit manufacturer based in Windsor, Connecticut, with no federal contract prime awardees or contract vehicle seats; its federal footprint consists entirely of project grants supporting preclinical and developmental work on multi-channel radiofrequency and pulsed-field ablation systems for cardiac arrhythmia treatment.
Sirona's federal grant portfolio centers on cardiac ablation technology development. The National Heart Lung and Blood Institute funded two grants totaling development of a multi-channel radiofrequency and pulsed-field energy source generator for cardiac ablation, awarded in May 2025 with ultimate completion dates of March 31, 2026 and March 31, 2028 respectively. The Defense Health Agency awarded a preclinical study grant for development of a multichannel dual-energy source mapping and ablation catheter, dated June 1, 2026 with completion scheduled for May 31, 2028. All three awards are prime grants; the company does not appear as a sub-recipient in any federal awards in the source data.
The company's federal customer base is highly concentrated. Two agencies account for 100% of awards: the National Heart Lung and Blood Institute (part of the Department of Health and Human Services) with 2 awards and the Defense Health Agency with 1 award. Combined federal dollars obligated across all awards total $637 thousand. Activity is nascent — two awards in 2025 and one in 2026 — with two awards reaching ultimate completion within the next twenty-four months, exposing the vendor to recompete risk on near-term renewals. Sirona's grant work focuses on developing proprietary multi-electrode, multi-configuration catheter designs with dual energy source capability, designed to reduce off-target tissue damage and improve procedure precision and safety in cardiac ablation therapy.
Quick answers
Is Sirona Medical Technologies, Inc. registered in SAM.gov?
Yes. Sirona Medical Technologies, Inc.'s SAM.gov registration is active through July 28, 2027.
What is Sirona Medical Technologies, Inc.'s CAGE code?
Sirona Medical Technologies, Inc.'s CAGE code is 19YF1, and its Unique Entity ID (UEI) is UZJPSMDMA814.
What is Sirona Medical Technologies, Inc.'s most recent federal award?
Sirona Medical Technologies, Inc.'s most recent federal grant award is Preclinical study for the development of a multichannel dual energy source mapping and ablation catheter (HT9425261E182), from Defense Health Agency, on June 1, 2026.
On GovTribe
See Sirona Medical Technologies, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors